MedTrace Logo

Effect of HCL Insulin Delivery System on Glycemic Control in Patients With T1D

NCT05924932 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2023-11-03

No results posted yet for this study

Summary

The goal of this study is compare the effect of hybrid closed loop system (HCL) for automatic insulin dosing treatment on the glycemic control of type 1 diabetes (T1D) in patient with different initial glycated hemoglobin.

Conditions

  • Diabetes Mellitus, Type 1

Interventions

DEVICE

Tandem t:slim X2 with hybrid closed loop system Control IQ, glucose sensor: Dexcom G6

type of hybrid close loop insulin delivery system

DEVICE

MiniMed 780G, with hybrid closed loop system SmartGuard, sensor Guardien 4

type of hybrid close loop insulin delivery system

Sponsors & Collaborators

  • Masaryk Hospital Usti nad Labem

    lead OTHER

Principal Investigators

  • Jiri Lastuvka · Masaryk hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-01
Primary Completion
2023-12-01
Completion
2024-05-01
FDA Device
Yes

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05924932 on ClinicalTrials.gov